Skip to main
HQY
HQY logo

HealthEquity (HQY) Stock Forecast & Price Target

HealthEquity (HQY) Analyst Ratings

Based on 15 analyst ratings
Buy
Strong Buy 33%
Buy 53%
Hold 13%
Sell 0%
Strong Sell 0%

Bulls say

HealthEquity Inc has demonstrated strong financial growth, with custodial revenue increasing by 15.3% year-over-year to $159.9 million, contributing to an adjusted EBITDA margin improvement of 466 basis points, reaching 44.0%. The company’s total revenue in the third quarter rose 7.2% to $322.2 million, driven notably by custodial revenue expansion, which exceeded both internal projections and consensus estimates. Additionally, there has been a positive trend in total accounts, which grew 5.0% year-over-year to 17.280 million, reflecting increased participation in various consumer-directed benefit accounts.

Bears say

HealthEquity's stock outlook is negatively impacted by its current trading valuation, which is at 6.4 times its updated FY/26 revenue estimate, below the average valuation of its high-growth SaaS peer group at 7.6 times, indicating a potential undervaluation relative to peers. Additionally, the company faced negative results attributed to a significant $30 million one-time legal settlement in Q3/25, which may contribute to investor concerns about operational stability and financial performance. Projections for FY/27 indicate modest revenue growth of 8.3% year-over-year, slightly below prior expectations, alongside declining adjusted EBITDA expectations compared to earlier estimates, suggesting potential limitations in profitability expansion moving forward.

HealthEquity (HQY) has been analyzed by 15 analysts, with a consensus rating of Buy. 33% of analysts recommend a Strong Buy, 53% recommend Buy, 13% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of HealthEquity and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About HealthEquity (HQY) Forecast

Analysts have given HealthEquity (HQY) a Buy based on their latest research and market trends.

According to 15 analysts, HealthEquity (HQY) has a Buy consensus rating as of Dec 13, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $119.60, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $119.60, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

HealthEquity (HQY)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.